News

FINEOS Secures Top Ten Spot in 2024 L&A Insurance Tech Ranking

FINEOS Secures Top Ten Spot in 2024 L&A Insurance Tech Ranking

FINEOS Ranked Among Top L&A Insurance Tech Providers

FINEOS Corporation has recently been acknowledged in the Everest Group's Leading 50™ Life & Annuity (L&A) Insurance Technology Providers report, solidifying its status as a leader in the life, accident, and health insurance technology sector for this year. This recognition reflects FINEOS's commitment to innovation and excellence in providing core systems that cater to the evolving needs of the insurance industry.

Overview of the Recognition Process

The Everest Group began by scrutinizing over 200 technology providers operating within the diverse L&A insurance, retirements, and pensions landscape. They utilized a comprehensive evaluation strategy that took into account various factors such as the company's revenue, line of business (LoB) coverage, geographical reach, and value-chain support. This rigorous filtering process culminated in the identification of the Leading 50™ Life & Annuity Insurance Technology Providers for 2024, in which FINEOS emerged as a leading contender.

Criteria for Ranking

FINEOS's ranking is a testament to several critical strengths, including its expansive operational scale, extensive technology offerings, and innovative solutions. The company has consistently demonstrated a high level of buyer satisfaction, impressive revenue figures, and significant year-over-year growth, showcasing its ability to adapt and thrive in the competitive insurance technology market.

Insights from Leadership

Michael Kelly, the CEO of FINEOS, expressed his pride regarding the company's top-tier position, stating, “We are pleased to be recognised by Everest Group in a top ten position among the Life & Annuity (L&A) Insurance Technology Providers for 2024. This recognition underscores the tremendous value that the FINEOS purpose-built platform delivers to employee benefits, life, accident, and health insurers around the globe.” His commitment to enhancing insurer capabilities illustrates the company's dedication to excellence.

The Impact of the Recognition

Being listed in the Everest Group's Leading 50™ not only highlights FINEOS's robust platform capabilities but also emphasizes the trust that significant insurers place in its services. With seven of the ten largest employee benefits insurers in the U.S. using its solutions and holding a 70% market share in group insurance in Australia, FINEOS has established itself as a dominant player in its field. This commitment to innovation and customer satisfaction is further evidenced by its increasing clientele across North America, Europe, and Asia Pacific.

FINEOS's Future Prospects

With its impressive track record and recognition, FINEOS is well-positioned for continued growth and success in the insurance tech domain. As it continues to innovate and enhance its platform, the company is likely to attract more insurance providers seeking to streamline their operations and improve customer engagement.

About FINEOS Corporation

FINEOS stands out as a leader in providing essential core systems designed for life, accident, and health insurers on a global scale. The company has solidified partnerships with major insurers, particularly in the U.S. where it dominates the employee benefits sector. With a dedicated team and strategically placed offices worldwide, FINEOS is committed to collaborating with forward-thinking insurers across various regions, further driving advancements in the insurance technology landscape.

Frequently Asked Questions

What recognition did FINEOS receive recently?

FINEOS was ranked in the top ten of Everest Group's Leading 50™ Life & Annuity Insurance Technology Providers report for 2024.

How does FINEOS compare to other companies?

FINEOS ranks highly among major technology providers in the L&A insurance sector based on revenue and client satisfaction.

What does FINEOS offer to insurers?

FINEOS provides core systems designed specifically for life, accident, and health insurers, enhancing their operational efficiency.

Who is the CEO of FINEOS, and what did he say about the recognition?

Michael Kelly is the CEO of FINEOS, and he expressed pride in the company being recognized among the top L&A technology providers.

How many major insurers utilize FINEOS's services?

Seven of the ten largest employee benefits insurers in the U.S. utilize FINEOS solutions, showcasing its industry leadership.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 106

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 99

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 227

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 203

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 211

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 155

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 138

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 136

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 193

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading

Top 5 Most Recently Viewed Articles

CNX Resources Reveals Third Quarter Results and Upcoming Call

Updated Category News Views 36

CNX Resources Corporation Financial Update CNX Resources Corporation (NYSE: CNX) is gearing up to announce its financial outcomes for the third quarter of 2024. This announcement is scheduled for 6:45 a.m. Eastern Time on a Thursday morning toward the end of October. During this time, CNX will also share essential materials, including remarks prepared for the quarter,...

Continue Reading
MBZUAI Enhances Research Collaboration with École Polytechnique

Updated Category News Views 183

Strengthening Research Cooperation Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) has officially expanded its strategic partnership with École Polytechnique, aiming for a more profound collaboration in artificial intelligence (AI) research. This new Collaborative Research Agreement is a significant step towards enhancing research capabilities in both...

Continue Reading
Projected Growth of Marine Collagen: Key Insights and Trends

Updated Category News Views 152

The Growing Marine Collagen Market The marine collagen market is set to experience significant growth in the coming years. As consumer awareness around health and beauty continues to rise, we see a shift in preference towards marine collagen, thanks to its impressive bioavailability and sustainable sourcing methods. Recent analyses reveal that this sector is predicted to...

Continue Reading
BioLife Solutions Prepares for Q1 2025 Financial Disclosure

Updated Category News Views 144

Exciting Financial Insights Awaiting from BioLife Solutions BioLife Solutions, Inc. (NASDAQ: BLFS) has announced that it will disclose its first quarter 2025 financial results, marking an important update for investors and stakeholders alike. This revelation is set to occur after the market closes, creating anticipation among those closely monitoring the company’s...

Continue Reading
FuboTV Achieves Record Subscriber Growth in North America

Updated Category News Views 174

FuboTV Reports Unprecedented Subscriber Growth FuboTV (NYSE: FUBO) has recently made headlines as it recorded the highest-ever growth in its North American subscriber base. This achievement highlights the company’s potential in the competitive streaming industry. The stock saw a notable increase on the day the company announced its earnings for the third quarter....

Continue Reading